Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

NCT06405217 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nanjing First Hospital, Nanjing Medical University